alpha-aminopyridine has been researched along with Cerebral Infarction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, N; Chen, K; Li, M; Li, X; Qin, Y; Wang, H; Xu, B; Xu, J | 1 |
| Hirata, K; Ishibashi, K; Ishii, K; Miura, Y; Toyohara, J | 1 |
| Ishibashi, K; Ishii, K; Kameyama, M; Tago, T; Toyohara, J | 1 |
3 other study(ies) available for alpha-aminopyridine and Cerebral Infarction
| Article | Year |
|---|---|
Roflumilast, a cyclic nucleotide phosphodiesterase 4 inhibitor, protects against cerebrovascular endothelial injury following cerebral ischemia/reperfusion by activating the Notch1/Hes1 pathway.
Topics: Aminopyridines; Animals; Benzamides; Blood-Brain Barrier; Brain Ischemia; Cerebral Infarction; Cyclopropanes; Endothelial Cells; Humans; Ischemic Stroke; Nucleotides, Cyclic; Phosphodiesterase 4 Inhibitors; Rats; Receptor, Notch1; Reperfusion; Reperfusion Injury; Transcription Factor HES-1 | 2022 |
Relationship between the temporal course of astrogliosis and symptom improvement in cerebral infarction: report of a case monitored using
Topics: Aged; Aminopyridines; Cerebral Infarction; Frontal Lobe; Gliosis; Humans; Male; Monoamine Oxidase; Positron-Emission Tomography; Quinolines; Somatosensory Cortex | 2020 |
Potential Use of 18F-THK5351 PET to Identify Wallerian Degeneration of the Pyramidal Tract Caused by Cerebral Infarction.
Topics: Adult; Aminopyridines; Cerebral Infarction; Humans; Male; Positron-Emission Tomography; Quinolines; Wallerian Degeneration | 2017 |